Opinion
Video
Author(s):
A comprehensive discussion on the value of therapies for Alzheimer disease based on cost vs outcome, and unmet needs in the overall treatment landscape.
Video content above is prompted by the following question(s):
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff